IL-17 in the Rheumatologist’s Line of Sight
Joint Authors
Truchetet, Marie-Elise
Mossalayi, M. Djavad
Boniface, Katia
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-18, 18 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-07-25
Country of Publication
Egypt
No. of Pages
18
Main Subjects
Abstract EN
Over the past decades, the identification of several new cytokines, including interleukin (IL)-17 and IL-23, and of new T helper cell subsets, including Th17 cells, has changed the vision of immunological processes.
The IL-17/Th17 pathway plays a critical role during the development of inflammation and autoimmunity, and targeting this pathway has become an attractive strategy for a number of diseases.
This review aims to describe the effects of IL-17 in the joint and its roles in the development of autoimmune and inflammatory arthritis.
Furthermore, biotherapies targeting directly or indirectly IL-17 in inflammatory rheumatisms will be developed.
American Psychological Association (APA)
Truchetet, Marie-Elise& Mossalayi, M. Djavad& Boniface, Katia. 2013. IL-17 in the Rheumatologist’s Line of Sight. BioMed Research International،Vol. 2013, no. 2013, pp.1-18.
https://search.emarefa.net/detail/BIM-1003927
Modern Language Association (MLA)
Truchetet, Marie-Elise…[et al.]. IL-17 in the Rheumatologist’s Line of Sight. BioMed Research International No. 2013 (2013), pp.1-18.
https://search.emarefa.net/detail/BIM-1003927
American Medical Association (AMA)
Truchetet, Marie-Elise& Mossalayi, M. Djavad& Boniface, Katia. IL-17 in the Rheumatologist’s Line of Sight. BioMed Research International. 2013. Vol. 2013, no. 2013, pp.1-18.
https://search.emarefa.net/detail/BIM-1003927
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1003927
